Eckuity Capital

Vivance’s Grand Debut at ASN 2024 in San Diego Our presence at ASN was a powerful showcase of Vivance’s mission to revolutionize kidney care. From impressive data to innovative product showcasing and the unwavering dedication of our team, this event highlighted the heart of Vivance’s journey. Here are some key moments from the conference: Viva Kompact Pre-Pivotal Study Insights: Our Viva Kompact pre-pivotal study data underscored a major milestone—no serious device-related safety events. In addition to meeting the primary endpoint of the study, we also resolved key improvements identified in the First-in-Human trial, achieving promising results in electrolyte balance, UF, and clearance. Notably, the study included a few patients who, for the very first time in the history of wearable PD, completed up to 30 days of use at home. Plus, we’ve learned what to fine-tune as we step into the pivotal phase. Introducing Viva Komfort: We unveiled our innovative On-Demand Dialysate Generation Prototype with an integrated APD device, thoughtfully designed to enhance accessibility and ensure long-term sustainability. Prioritizing user experience and treatment cost, this device aims to make home PD more practical and appealing. The response was overwhelming! Vivance’s Team Spirit: Our debut at ASN wouldn’t have been possible without the dedication of our incredible team. Huge thanks to Priyanka Arya for single-handedly orchestrating the event, with Mandar Gori’s leadership setting the direction. Special appreciation to Bipin Dodkal, Sanjay Singh, Marcin Pawlak, Alessandro Donadio, Sheena Gow and the entire Vivance team back in Singapore and India. It was exhilarating to have our clinical advisors by our side, including Dr. Martin Schreiber, Jr M.D., Dr Marjorie Foo, Dr Arsh Jain, Dr Edwina Brown, Dr Prashanth Kumar, MD, MPH. Their presence and insights were truly inspiring. We were grateful to have board members Abel Ang, Jeff Chi, and Kimberly Oleson with us at the event, enthusiastically cheering on our team and celebrating this milestone together. ASN 2024 was just one key pit stop in our journey of continuously pushing the boundaries of kidney care innovation. Keep watching this space for more updates! Note: Vivance's products are currently in the R&D stage and are not commercially available anywhere. #ASN2024 #Vivance #KidneyCareInnovation #TeamVivance #HealthcareTransformation American Society of Nephrology Dr. Suresh Palale Joel Preetham Fernandes Daniel Tan Koh Yau Luong Cong Jiang Jason Lim Tze Chern Carol Su Yu Lim Kee Wee Soo Derek Neo Enterprise Singapore Vickers Venture Partners Advanced MedTech Lion X Ventures GS Ventures Eckuity Capital Singapore General Hospital

At #GHE24, Mr. Mark Goldstone emphasized Saudi Arabia’s significant progress in its healthcare system transformation, highlighting the critical role of technology in advancing disease prevention and improving the efficiency of care delivery.

Huge kudos to team Eckuity Capital for one of the best ever AGMs I have attended (over my 20+ years in #privateequity): - incredible attendees with deep #healthcare expertise from all over the world and across the entire ecosystem of health - dense agenda with deep-dives and good mix of topics around the redefinition of #patientcare with some of their portfolio companies - outstanding location and impeccable logistics in #marrakesh with the entire GP team and extended parties present on site to welcome us 🙌🏼🙌🏼🙌🏼 to Youssef Sebban Vishal Jain Victoria Manax Rutson, MD Mark Goldstone Philippe Douste-Blazy and the rest of the team - esp Sarah Binebine I am impressed 🤩 and grateful to be part of it and be able to speak alongside expectional investors like John Hood tomorrow 🇲🇦🌎⚕️⛑️🇬🇧🇺🇸🇪🇺 #bestinclassgp #healthtech #venturecapital #growthinvesting #familyoffices

It's official! I'm attending HLTH 2024, happening Oct 20 - 23 in Las Vegas. Join me at Healthcare's #1 must-attend innovation event https://lnkd.in/eJtRUzYs #HLTHUSA #healthcareinnovation #healthcare #bebold